Legal & General Group
TMO icon

Legal & General Group’s Thermo Fisher Scientific TMO Stock Holding History

Legal & General Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.17B Sell
2,370,531
-48,051
-2% -$26.1M 0.27% 67
2025
Q4 		$1.4B Sell
2,418,582
-44,406
-2% -$25.1M 0.31% 49
2025
Q3 		$1.19B Buy
2,462,988
+124,432
+5% +$57.9M 0.27% 62
2025
Q2 		$948M Buy
2,338,556
+59,738
+3% +$25M 0.24% 73
2025
Q1 		$1.13B Buy
2,278,818
+16,278
+0.7% +$8.82M 0.31% 51
2024
Q4 		$1.18B Sell
2,262,540
-110,111
-5% -$60.5M 0.31% 44
2024
Q3 		$1.47B Buy
2,372,651
+18,579
+0.8% +$11M 0.39% 36
2024
Q2 		$1.3B Sell
2,354,072
-130,029
-5% -$74.5M 0.37% 37
2024
Q1 		$1.44B Sell
2,484,101
-53,485
-2% -$30M 0.42% 35
2023
Q4 		$1.35B Buy
2,537,586
+20,203
+0.8% +$9.78M 0.42% 36
2023
Q3 		$1.27B Sell
2,517,383
-92,725
-4% -$49.4M 0.44% 33
2023
Q2 		$1.36B Buy
2,610,108
+50,802
+2% +$27.4M 0.44% 36
2023
Q1 		$1.48B Buy
2,559,306
+32,431
+1% +$18.3M 0.53% 28
2022
Q4 		$1.39B Sell
2,526,875
-72,003
-3% -$38.2M 0.53% 28
2022
Q3 		$1.32B Sell
2,598,878
-127,345
-5% -$71.3M 0.52% 29
2022
Q2 		$1.48B Sell
2,726,223
-25,749
-0.9% -$14.2M 0.52% 29
2022
Q1 		$1.63B Buy
2,751,972
+174,785
+7% +$100M 0.49% 30
2021
Q4 		$1.72B Sell
2,577,187
-123,129
-5% -$76.9M 0.52% 25
2021
Q3 		$1.54B Buy
2,700,316
+129,279
+5% +$71M 0.5% 29
2021
Q2 		$1.3B Buy
2,571,037
+144,560
+6% +$68.2M 0.43% 38
2021
Q1 		$1.11B Sell
2,426,477
-37,838
-2% -$18.1M 0.41% 42
2020
Q4 		$1.15B Buy
2,464,315
+43,584
+2% +$20.4M 0.45% 41
2020
Q3 		$1.07B Sell
2,420,731
-105,133
-4% -$43.4M 0.48% 37
2020
Q2 		$915M Sell
2,525,864
-51,210
-2% -$17.2M 0.44% 44
2020
Q1 		$731M Buy
2,577,074
+81,301
+3% +$25.6M 0.43% 45
2019
Q4 		$811M Buy
2,495,773
+58,312
+2% +$17.7M 0.39% 47
2019
Q3 		$710M Sell
2,437,461
-4,408
-0.2% -$1.26M 0.37% 48
2019
Q2 		$717M Sell
2,441,869
-12,395
-0.5% -$3.41M 0.39% 47
2019
Q1 		$672M Buy
2,454,264
+476,994
+24% +$119M 0.38% 53
2018
Q4 		$442M Buy
1,977,270
+130,064
+7% +$30.5M 0.34% 58
2018
Q3 		$451M Buy
1,847,206
+70,872
+4% +$16.3M 0.32% 62
2018
Q2 		$368M Sell
1,776,334
-77,317
-4% -$16.4M 0.28% 73
2018
Q1 		$383M Sell
1,853,651
-117,232
-6% -$24.6M 0.29% 70
2017
Q4 		$374M Buy
1,970,883
+2,433
+0.1% +$466K 0.27% 79
2017
Q3 		$372M Buy
1,968,450
+41,041
+2% +$7.43M 0.28% 75
2017
Q2 		$336M Buy
1,927,409
+63,359
+3% +$10.6M 0.27% 81
2017
Q1 		$286M Buy
1,864,050
+69,279
+4% +$10.6M 0.24% 91
2016
Q4 		$253M Buy
1,794,771
+25,400
+1% +$3.74M 0.24% 96
2016
Q3 		$281M Sell
1,769,371
-37,585
-2% -$5.79M 0.29% 77
2016
Q2 		$267M Buy
1,806,956
+101,399
+6% +$15M 0.28% 77
2016
Q1 		$241M Buy
1,705,557
+16,966
+1% +$2.27M 0.27% 86
2015
Q4 		$240M Buy
1,688,591
+36,270
+2% +$4.84M 0.27% 83
2015
Q3 		$202M Buy
1,652,321
+50,142
+3% +$6.53M 0.25% 90
2015
Q2 		$208M Buy
1,602,179
+22,497
+1% +$2.93M 0.24% 96
2015
Q1 		$212M Sell
1,579,682
-18,114
-1% -$2.34M 0.25% 90
2014
Q4 		$200M Sell
1,597,796
-71,844
-4% -$8.74M 0.24% 100
2014
Q3 		$203M Sell
1,669,640
-41,986
-2% -$5.1M 0.24% 98
2014
Q2 		$202M Buy
1,711,626
+69,926
+4% +$8.23M 0.24% 101
2014
Q1 		$197M Buy
1,641,700
+35,932
+2% +$4.27M 0.24% 99
2013
Q4 		$179M Buy
1,605,768
+4,652
+0.3% +$463K 0.22% 114
2013
Q3 		$148M Sell
1,601,116
-21,218
-1% -$1.92M 0.19% 122
2013
Q2 		$137M Buy
+1,622,334
New +$135M 0.19% 122

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Legal & General Group's TMO Position: Q1 2026 in Review

Legal & General Group reduced its Thermo Fisher Scientific (TMO) stake by 2% in Q1 2026, selling an estimated $26.1M and leaving 2,370,531 shares worth $1.17B. The position accounts for 0.27% of the portfolio, ranked #67.

Legal & General Group first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.72B in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Legal & General Group held 2,370,531 shares of Thermo Fisher Scientific worth $1.17B as of Q1 2026.
  • Legal & General Group sold 48,051 Thermo Fisher Scientific shares in Q1 2026, an estimated $26.1M.
  • Thermo Fisher Scientific made up 0.27% of Legal & General Group's portfolio in Q1 2026, its #67 holding.
  • Legal & General Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Legal & General Group's Thermo Fisher Scientific position peaked at $1.72B in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.